Virginie Vignard

1.4k total citations
27 papers, 858 citations indexed

About

Virginie Vignard is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Virginie Vignard has authored 27 papers receiving a total of 858 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Immunology, 14 papers in Oncology and 9 papers in Molecular Biology. Recurrent topics in Virginie Vignard's work include Immunotherapy and Immune Responses (15 papers), T-cell and B-cell Immunology (14 papers) and CAR-T cell therapy research (12 papers). Virginie Vignard is often cited by papers focused on Immunotherapy and Immune Responses (15 papers), T-cell and B-cell Immunology (14 papers) and CAR-T cell therapy research (12 papers). Virginie Vignard collaborates with scholars based in France, United Kingdom and United States. Virginie Vignard's co-authors include Nathalie Labarrière, Brigitte Dréno, Amir Khammari, Francine Jotereau, François Lang, Yann Godet, Agnès Moreau‐Aubry, Delphine Fradin, Jean‐François Fonteneau and Nicolas Jouand and has published in prestigious journals such as The Journal of Experimental Medicine, The Journal of Immunology and PLoS ONE.

In The Last Decade

Virginie Vignard

27 papers receiving 850 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Virginie Vignard France 17 582 429 347 125 110 27 858
Jan Martínek United States 7 492 0.8× 397 0.9× 244 0.7× 75 0.6× 117 1.1× 14 924
Assaf Marcus United States 9 988 1.7× 430 1.0× 424 1.2× 78 0.6× 57 0.5× 9 1.2k
Michaël Hebeisen Switzerland 14 718 1.2× 601 1.4× 329 0.9× 139 1.1× 77 0.7× 24 1.0k
Alireza Labani‐Motlagh Sweden 6 363 0.6× 352 0.8× 282 0.8× 125 1.0× 78 0.7× 7 709
Nahoko Suzuki Japan 8 505 0.9× 393 0.9× 382 1.1× 93 0.7× 124 1.1× 11 1.1k
Nourredine Himoudi United Kingdom 14 351 0.6× 292 0.7× 164 0.5× 50 0.4× 60 0.5× 18 599
Zhenqing Feng China 14 204 0.4× 368 0.9× 261 0.8× 150 1.2× 84 0.8× 26 674
Françoise Quintin‐Colonna France 13 569 1.0× 362 0.8× 216 0.6× 70 0.6× 106 1.0× 19 905
Selina J. Keppler Germany 16 476 0.8× 228 0.5× 273 0.8× 49 0.4× 77 0.7× 24 834
Smita S. Chandran United States 13 682 1.2× 670 1.6× 261 0.8× 46 0.4× 131 1.2× 19 1.0k

Countries citing papers authored by Virginie Vignard

Since Specialization
Citations

This map shows the geographic impact of Virginie Vignard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Virginie Vignard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Virginie Vignard more than expected).

Fields of papers citing papers by Virginie Vignard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Virginie Vignard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Virginie Vignard. The network helps show where Virginie Vignard may publish in the future.

Co-authorship network of co-authors of Virginie Vignard

This figure shows the co-authorship network connecting the top 25 collaborators of Virginie Vignard. A scholar is included among the top collaborators of Virginie Vignard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Virginie Vignard. Virginie Vignard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bezieau, Stéphane, Wallid Deb, Sandra Mercier, et al.. (2023). Understanding neurodevelopmental proteasomopathies as new rare disease entities: A review of current concepts, molecular biomarkers, and perspectives. Genes & Diseases. 11(6). 101130–101130. 2 indexed citations
2.
Dréno, Brigitte, Amir Khammari, Virginie Vignard, et al.. (2021). Phase I/II clinical trial of adoptive cell transfer of sorted specific T cells for metastatic melanoma patients. Cancer Immunology Immunotherapy. 70(10). 3015–3030. 11 indexed citations
3.
Vignard, Virginie, Nadège Marec, Gwennan André‐Grégoire, et al.. (2019). MicroRNAs in Tumor Exosomes Drive Immune Escape in Melanoma. Cancer Immunology Research. 8(2). 255–267. 121 indexed citations
4.
Samimi, M., Houssem Benlalam, Pauline Gaboriaud, et al.. (2019). Viral and tumor antigen-specific CD8 T-cell responses in Merkel cell carcinoma. Cellular Immunology. 344. 103961–103961. 14 indexed citations
5.
Vignard, Virginie & Delphine Fradin. (2018). Non-Coding RNAs in Cutaneous Melanoma Development, Progression and Dissemination. HAL (Le Centre pour la Communication Scientifique Directe). 2(2). 1–21. 2 indexed citations
6.
Simon, Sylvain, Zhong Wu, Virginie Vignard, et al.. (2018). TCR Analyses of Two Vast and Shared Melanoma Antigen-Specific T Cell Repertoires: Common and Specific Features. Frontiers in Immunology. 9. 1962–1962. 11 indexed citations
7.
Simon, Sylvain, Virginie Vignard, Émilie Varey, et al.. (2017). Emergence of High-Avidity Melan-A–Specific Clonotypes as a Reflection of Anti–PD-1 Clinical Efficacy. Cancer Research. 77(24). 7083–7093. 17 indexed citations
8.
Boisgerault, Nicolas, Soizic Dutoit, Virginie Vignard, et al.. (2017). Oncolytic viruses sensitize human tumor cells for NY-ESO-1 tumor antigen recognition by CD4+ effector T cells.. OncoImmunology. 7(3). e1407897–e1407897. 24 indexed citations
9.
Simon, Sylvain, Virginie Vignard, Brigitte Dréno, et al.. (2015). PD-1 expression conditions T cell avidity within an antigen-specific repertoire. OncoImmunology. 5(1). e1104448–e1104448. 48 indexed citations
10.
Vignard, Virginie, et al.. (2013). Overexpression of Meloe Gene in Melanomas Is Controlled Both by Specific Transcription Factors and Hypomethylation. PLoS ONE. 8(9). e75421–e75421. 7 indexed citations
11.
Carbonnelle, Delphine, Virginie Vignard, Agnès Moreau‐Aubry, et al.. (2013). The Melanoma Antigens MELOE-1 and MELOE-2 Are Translated from a Bona Fide Polycistronic mRNA Containing Functional IRES Sequences. PLoS ONE. 8(9). e75233–e75233. 28 indexed citations
12.
Roulois, David, Virginie Vignard, Fabien Gueugnon, et al.. (2011). Recognition of pleural mesothelioma by mucin-1(950–958)/human leukocyte antigen A*0201-specific CD8+ T-cells. European Respiratory Journal. 38(5). 1117–1126. 13 indexed citations
13.
Allard, Mathilde, Romain Oger, Virginie Vignard, et al.. (2011). Serum Soluble HLA-E in Melanoma: A New Potential Immune-Related Marker in Cancer. PLoS ONE. 6(6). e21118–e21118. 48 indexed citations
14.
Moreau‐Aubry, Agnès, Virginie Vignard, Yann Godet, et al.. (2010). Double Positive CD4CD8 αβ T Cells: A New Tumor-Reactive Population in Human Melanomas. PLoS ONE. 5(1). e8437–e8437. 74 indexed citations
15.
Godet, Yann, Virginie Vignard, Dirk Schadendorf, et al.. (2010). Frequent occurrence of high affinity T cells against MELOE‐1 makes this antigen an attractive target for melanoma immunotherapy. European Journal of Immunology. 40(6). 1786–1794. 23 indexed citations
16.
17.
Khammari, Amir, Nathalie Labarrière, Virginie Vignard, et al.. (2009). Treatment of Metastatic Melanoma with Autologous Melan-A/Mart-1-Specific Cytotoxic T Lymphocyte Clones. Journal of Investigative Dermatology. 129(12). 2835–2842. 58 indexed citations
18.
Godet, Yann, Agnès Moreau‐Aubry, Virginie Vignard, et al.. (2009). An additional ORF on meloe cDNA encodes a new melanoma antigen, MELOE-2, recognized by melanoma-specific T cells in the HLA-A2 context. Cancer Immunology Immunotherapy. 59(3). 431–439. 16 indexed citations
19.
Benlalam, Houssem, Virginie Vignard, Amir Khammari, et al.. (2006). Infusion of Melan-A/Mart-1 specific tumor-infiltrating lymphocytes enhanced relapse-free survival of melanoma patients. Cancer Immunology Immunotherapy. 56(4). 515–526. 33 indexed citations
20.
Vignard, Virginie, Brigitte Lemercier, Apiradee Lim, et al.. (2005). Adoptive Transfer of Tumor-Reactive Melan-A-Specific CTL Clones in Melanoma Patients Is Followed by Increased Frequencies of Additional Melan-A-Specific T Cells. The Journal of Immunology. 175(7). 4797–4805. 77 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jan Martínek Breakdown of academic impact, for papers by Assaf Marcus Breakdown of academic impact, for papers by Michaël Hebeisen Breakdown of academic impact, for papers by Alireza Labani‐Motlagh Breakdown of academic impact, for papers by Nahoko Suzuki Breakdown of academic impact, for papers by Nourredine Himoudi Breakdown of academic impact, for papers by Zhenqing Feng Breakdown of academic impact, for papers by Françoise Quintin‐Colonna Breakdown of academic impact, for papers by Selina J. Keppler Breakdown of academic impact, for papers by Smita S. Chandran
Rankless by CCL
2026